- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
- MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
- MacroGenics to Participate in Upcoming Investor Conferences
- MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
- MacroGenics to Participate in Upcoming Investor Conference
- MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
- MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
- MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.53 |
---|---|
High | 4.88 |
Low | 3.14 |
Bid | 3.33 |
Offer | 3.36 |
Previous close | 14.67 |
Average volume | 4.66m |
---|---|
Shares outstanding | 62.56m |
Free float | 60.31m |
P/E (TTM) | -- |
Market cap | 917.76m USD |
EPS (TTM) | -0.1525 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:00 BST.
More ▼